Autorisation d’accès précoce octroyée à la spécialité IMCIVREE (setmélanotide).
See also
Décision d'accès précoce
18/07/2022
eNrdWE1z2jAQvedXML7LBhMS0jFkWpq0zDRTSsK00wsj5AVEheTog5D++so2aUnHbhoRXcKBsbXy27W07+3Kyfl2zRobkIoK3gtaYTNoACcipXzRCyY3l6gbnPePkhXe4L1pdl4Yx0GDMKxUL8it4QwwV+G3q0/vwT4PMugfNRIxWwHRj+YZTVn4EavlFc7yOY1kI2jaWINeirQXZEYXo41EaWmj6N8J+UNlmEAS7Ub2ravp8f54EuVg/4FqFMhPmC8qQYE7YRIjJXA9wBoWQt5XQmcybU3js+5J66zr5ISqMShhJIER1suRFBuaQlrpa46ZAicn87v0GuSGgc6dVIJHK7JWTuB4hbdjuB1WB/3WWgd6q1ETtU7bcfvE/lrd+MTJldxbqur0sS8RZdN2uxN34rMIeJQCoXmWIx434xg143Y3SkmkYI1Sg07RylBm1wUVVjtChL1dAEoBMYyW2GhA9k9IqotBhbm9yITU9mJnUVjnHlKECQGFMmkZQx4gVGYjwCx/nK4J3UgAx0QZ5U6ZpxShavA43T35kXD7ZCqmVGUM34crlbkuFZbYmkFaUfL3Ivkb3Egrk8yu2V/43DAWPTPqyU7EPEWca+RAGK5rtOxy7LoQA2FJsa3fUTf51dtdLlJQLwf7U/Dq0jMyM0aJq75aBTSg9GQ8rJfXV6tM77CCifQnTV8pT8WdennJ208xT9EXG8KeaB46HWdGf7f5XFN7L4wUGURWDKk6ROOGfC4OVTdLkWqoB4K8Tm4UfakgmEFNZ4ocVdeS4qGR9kY7f5QuDZWgHy5uXHP1iwF5f13cVkLTtPc7y9xKko86Z5lRG/jzeVbKzT/PLHMyjbunx92224nFyGo1W2qdqTdRtMSq5Fs4l+Hrrnt7fY+/k5uX5qpsNsva4Sn0WdkUPCNXXHn/VO916Hli9/zu3FLpQ0sDB2xEWSK8Cfnw4uVrw5/DhLewR4+0zJ+bovEvFMNXD2hm1Q3gQdXI7iu/lFYdPs/ntOZ7Wm1eJlH5La9/lET5d7z+0S9rX62E
tMLXnswhV36TcRvH